Dermapharm Holding SE Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	132.41	113.79	62.37	134.24	209.58
Depreciation & Amortization	35.45	34.93	33.38	23.7	20.66
Other Amortization	44.82	43.53	52.57	27.73	24.59
Loss (Gain) From Sale of Assets	1.17	2.72	-2.57	-0.2	-0.4
Asset Writedown & Restructuring Costs	11.74	8.32	15.82	43.48	9.91
Loss (Gain) on Equity Investments	-4.34	-1.52	7.16	13.54	-0.32
Other Operating Activities	1.58	17.67	41.65	50.18	32.62
Change in Other Net Operating Assets	6.32	-18.06	9.04	-4.14	-46.27
Operating Cash Flow	229.15	201.38	219.42	288.53	250.37
Operating Cash Flow Growth	13.79%	-8.22%	-23.95%	15.24%	90.98%
Capital Expenditures	-42.12	-38.24	-41.54	-39.01	-61.2
Sale of Property, Plant & Equipment	0.8	3.79	2.82	0.68	2.52
Cash Acquisitions	-51.24	-	-389.4	-69.79	-22.51
Investment in Securities	-9.82	0.3	7.95	3.93	-48.25
Other Investing Activities	4.13	4.53	4.74	5.18	0.1
Investing Cash Flow	-98.24	-29.61	-415.43	-99.01	-129.35
Long-Term Debt Issued	170	111.17	715	469.95	10
Long-Term Debt Repaid	-108.22	-219.3	-420.86	-541.19	-35.91
Net Debt Issued (Repaid)	61.78	-108.13	294.14	-71.24	-25.91
Common Dividends Paid	-48.46	-47.38	-56.53	-116.83	-47.38
Other Financing Activities	-59.43	-53.66	-33.07	-11.69	-7.69
Financing Cash Flow	-46.11	-209.17	204.54	-199.77	-80.98
Foreign Exchange Rate Adjustments	-2.69	-0.04	-0	-0.15	1.07
Miscellaneous Cash Flow Adjustments	-	0	-0.83	-	0
Net Cash Flow	82.12	-37.44	7.7	-10.4	41.11
Free Cash Flow	187.03	163.14	177.88	249.52	189.17
Free Cash Flow Growth	14.64%	-8.29%	-28.71%	31.91%	109.48%
Free Cash Flow Margin	15.87%	13.65%	15.46%	23.98%	19.70%
Free Cash Flow Per Share	3.47	3.03	3.30	4.63	3.51
Cash Interest Paid	51.77	53.65	33.07	7.76	7.69
Cash Income Tax Paid	89.89	83.84	65.37	40.59	44.85
Levered Free Cash Flow	100.96	99.52	106.43	218.88	127.86
Unlevered Free Cash Flow	131.38	136.03	140.78	226.59	133.38
Change in Working Capital	6.32	-18.06	9.04	-4.14	-46.27

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.